NFKB1 and neoplasm: EMMPRIN activation will mainly initiate PI3K, MAPKs, and NF-κB pathways, promoting the growth, angiogenesis, dissemination, and inflammation of tumor cells (Xin et al., 2016; Dana et al., 2021).